Ciaffoni Joseph — SEC Form 4 filings

SEC reporting owner CIK 1443841. 3 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-02-14 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
COLLEGIUM PHARMACEUTICAL, INC (COLL)President and CEO, Director14
Indivior Pharmaceuticals, Inc. (INDV)Chief Executive Officer, Director24

Form 4 filings — Ciaffoni Joseph

FiledFormIssuerReported transactionsSource
2026-06-234Indivior Pharmaceuticals, Inc. (INDV)Option exercise (M): 1,266,903 · Tax withholding (F): 612,549 @ $38.32 · Option exercise (M): 1,266,903 (derivative)EDGAR
2026-02-124Indivior Pharmaceuticals, Inc. (INDV)Grant/award (A): 79,976 @ $0EDGAR
2024-02-144COLLEGIUM PHARMACEUTICAL, INC (COLL)Grant/award (A): 119,000 @ $0 · Grant/award (A): 179,734 @ $0 · Tax withholding (F): 47,445 @ $33.70 · Tax withholding (F): 81,422 @ $33.70EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1443841 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →